Charlotte Elisabet Edenius
Director/Board Member bei KANCERA AB
Profil
Charlotte Elisabet Edenius founded Gesynta Pharma AB in 2017, where she is working as Director & Clinical director from 2017.
Dr. Edenius also currently works at Allmora Life Science AB, as Chief Executive Officer & Director and Kancera AB, as Independent Director from 2016.
Dr. Edenius also formerly worked at Karolinska Institutet Innovations AB, as Director, Qlucore AB, as Director, Karolinska Development AB, as Director from 2012 to 2015, Mendus AB, as Independent Director, SynAct Pharma AB, as Director, Aptahem AB, as Director, Medivir AB, as Executive Vice President-Development in 2015, Orexo AB, as Chief Scientific Officer, and Biolipox AB, as Chief Scientific Officer & Vice President.
Dr. Edenius received her doctorate degree from Karolinska Institutet.
Aktive Positionen von Charlotte Elisabet Edenius
Unternehmen | Position | Beginn |
---|---|---|
KANCERA AB | Director/Board Member | 01.01.2016 |
Allmora Life Science AB
Allmora Life Science AB Forest ProductsNon-Energy Minerals Allmora Life Science AB is a Swedish company that operates sawmills. The private company is based in Stockholm, Sweden. The CEO of the company is Charlotte Elisabet Edenius. | Chief Executive Officer | - |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Founder | 01.01.2017 |
Ehemalige bekannte Positionen von Charlotte Elisabet Edenius
Unternehmen | Position | Ende |
---|---|---|
SYNACT PHARMA AB | Director/Board Member | 21.03.2019 |
MEDIVIR AB | Chief Tech/Sci/R&D Officer | 24.03.2015 |
OREXO AB | Chief Tech/Sci/R&D Officer | 01.01.2012 |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Director/Board Member | - |
MENDUS AB | Director/Board Member | - |
Ausbildung von Charlotte Elisabet Edenius
Karolinska Institutet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 8 |
---|---|
MEDIVIR AB | Health Technology |
OREXO AB | Health Technology |
QLUCORE AB | Technology Services |
KANCERA AB | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
MENDUS AB | Health Technology |
SYNACT PHARMA AB | Health Technology |
Health Technology |
Private Unternehmen | 4 |
---|---|
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
Allmora Life Science AB
Allmora Life Science AB Forest ProductsNon-Energy Minerals Allmora Life Science AB is a Swedish company that operates sawmills. The private company is based in Stockholm, Sweden. The CEO of the company is Charlotte Elisabet Edenius. | Non-Energy Minerals |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |